Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pain Pract ; 11(1): 103-6, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-20642486

RESUMEN

BACKGROUND: Implanted delivery systems for intrathecal drug administration have become more common in the management of nonmalignant pain. Many postprocedural complications have been described in the literature including infection and headache provoked by position changes. Determining the etiology of a postimplant headache is important particularly when considering the possibility of a life-threatening infection. CASE REPORT: We present a patient who underwent placement of an implantable drug delivery system (IDDS) for intractable abdominal pain that developed positional headaches, and significant neck and back pain. Attempted cerebrospinal fluid aspiration reproduced her symptoms and imaging revealed a malpositioned intraspinal catheter tip approximated to the meninges. Revision of the system completely relieved her symptoms. CONCLUSION: Meningismus from malpositioned catheters is a rare complication that can mimic meningitis but should be considered in the differential for postimplant headaches. Given the increased use of IDDS, it is important to recognize and evaluate postimplant complication and treat it appropriately. We discuss this case report and appropriate work-up and differential diagnosis for meningismus following implant.


Asunto(s)
Catéteres/efectos adversos , Bombas de Infusión Implantables/efectos adversos , Meningismo/etiología , Dolor Abdominal/tratamiento farmacológico , Adulto , Femenino , Humanos , Imagen por Resonancia Magnética , Médula Espinal/patología
2.
Clin J Pain ; 27(4): 352-4, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21494183

RESUMEN

OBJECTIVE: We report a case of a 59-year-old female with severe TN who experienced satisfactory symptom relief from a single-shot trial of intrathecal ziconotide. METHOD: Performed a 1 µg single-shot trial of Prialt. RESULTS: Report of satisfaction, no side effects, and complete face and back relief briefly but most notably relief from the TN. DISCUSSION: Ziconotide should be considered for treatment of TN, although further investigation is recommended.


Asunto(s)
Analgésicos no Narcóticos/administración & dosificación , Neuralgia del Trigémino/tratamiento farmacológico , omega-Conotoxinas/administración & dosificación , Femenino , Humanos , Inyecciones Espinales/métodos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA